Ending the pandemic will require innovation and access
Long after the sun goes down, the work of America’s biopharmaceutical companies continues deep into the night. Researchers and scientists labor around the clock, developing new ways to diagnose, treat and cure COVID-19. While they do, so many of the people they’re working to help stare at the ceiling and wonder how they will afford